Asthma and Respiratory Foundation NZ child and adolescent asthma guidelines: a quick reference guide
- PMID: 29197898
Asthma and Respiratory Foundation NZ child and adolescent asthma guidelines: a quick reference guide
Abstract
The purpose of the New Zealand Child and adolescent asthma guidelines: a quick reference guide is to provide simple, practical, evidence-based recommendations for the diagnosis, assessment and management of asthma in children and adolescents in New Zealand, with the aim of improving outcomes and reducing inequities. The intended users are health professionals responsible for delivering asthma care in the community and hospital emergency department settings, and those responsible for the training of such health professionals.
Conflict of interest statement
Dr Harwood reports personal fees from Astra Zeneca Limited outside the submitted work; Dr Reid reports affiliation with Contract Research outside the submitted work; Dr Asher reports one grant from Boehringer Ingelheim New Zealand outside the submitted work; Dr Ingham reports personal fees from Te Hā Ora: The Asthma & Respiratory Foundation of New Zealand, grants from Janssen Research & Development, non-financial support from Astra Zeneca, outside the submitted work; Teresa Demetriou reports grants from REX Medical outside the submitted work.
Similar articles
-
Asthma and Respiratory Foundation NZ adult asthma guidelines: a quick reference guide.N Z Med J. 2016 Nov 18;129(1445):83-102. N Z Med J. 2016. PMID: 27857242
-
Asthma and Respiratory Foundation NZ Adolescent and Adult Asthma Guidelines 2020: a quick reference guide.N Z Med J. 2020 Jun 26;133(1517):73-99. N Z Med J. 2020. PMID: 32595223 Review.
-
New Zealand COPD Guidelines: Quick Reference Guide.N Z Med J. 2021 Feb 19;134(1530):76-110. N Z Med J. 2021. PMID: 33651780
-
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138. doi: 10.1016/j.jaci.2007.09.043. J Allergy Clin Immunol. 2007. PMID: 17983880
-
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.CMAJ. 1999 Nov 30;161(11 Suppl):S1-61. CMAJ. 1999. PMID: 10906907 Free PMC article. Review.
Cited by
-
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma.ERJ Open Res. 2021 Oct 11;7(4):00271-2021. doi: 10.1183/23120541.00271-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34853785 Free PMC article.
-
Management of asthma exacerbation in the emergency departments.Int J Pediatr Adolesc Med. 2019 Jun;6(2):61-67. doi: 10.1016/j.ijpam.2019.02.001. Epub 2019 Mar 15. Int J Pediatr Adolesc Med. 2019. PMID: 31388549 Free PMC article. Review. No abstract available.
-
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy.Breathe (Sheff). 2021 Dec;17(4):210113. doi: 10.1183/20734735.0113-2021. Breathe (Sheff). 2021. PMID: 35035570 Free PMC article. Review.
-
Treatment patterns and frequency of key outcomes in acute severe asthma in children: a Paediatric Research in Emergency Departments International Collaborative (PREDICT) multicentre cohort study.BMJ Open Respir Res. 2022 Mar;9(1):e001137. doi: 10.1136/bmjresp-2021-001137. BMJ Open Respir Res. 2022. PMID: 35301198 Free PMC article.
-
Management of asthma exacerbations in the paediatric population: a systematic review.Eur Respir Rev. 2021 Jul 13;30(161):200367. doi: 10.1183/16000617.0367-2020. Print 2021 Sep 30. Eur Respir Rev. 2021. PMID: 34261742 Free PMC article.